发明名称 |
Oral pharmaceutical dosage forms |
摘要 |
Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided. |
申请公布号 |
US9616055(B2) |
申请公布日期 |
2017.04.11 |
申请号 |
US201514791073 |
申请日期 |
2015.07.02 |
申请人 |
Durect Corporation |
发明人 |
Scicinski Jan J.;van Osdol William W.;Su Huey-Ching;Arenberg Michael H.;Shah Jaymin |
分类号 |
A61K31/4458;A61K9/00;A61K9/16;A61K9/48;A61K9/50 |
主分类号 |
A61K31/4458 |
代理机构 |
Bozicevic, Field & Francis LLP |
代理人 |
Rubin Michael B.;Bozicevic, Field & Francis LLP |
主权项 |
1. An oral controlled release dosage form comprising a formulation comprising:
methylphenidate at about 5 to about 30 wt % relative to the total weight of the formulation; sucrose acetate isobutyrate (SAIB) at about 30 to about 45 wt % relative to the total weight of the formulation; a rheology modifier at about 2 to about 15 wt % relative to the total weight of the formulation; a network former at about 2 to about 10 wt % relative to the total weight of the formulation; a solvent at about 15 to about 40 wt % relative to the total weight of the formulation; a viscosity enhancing agent at about 0.1 to about 2 wt % relative to the total weight of the formulation; and a saturated polyglycolized glyceride at about 0.01 to about 5 wt % relative to the total weight of the formulation. |
地址 |
Cupertino CA US |